The effect of azithromycin on reactive oxygen species in rosacea

Bakar O., Demircay Z., YÜKSEL M., Haklar G., Sanisoglu Y.

CLINICAL AND EXPERIMENTAL DERMATOLOGY, cilt.32, sa.2, ss.197-200, 2007 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 2
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1111/j.1365-2230.2006.02322.x
  • Dergi Adı: CLINICAL AND EXPERIMENTAL DERMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.197-200
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Background: Recent evidence suggests that inflammation in rosacea is associated with generation of reactive oxygen species (ROS) that are released by inflammatory cells. The efficacy of current therapeutic agents for rosacea such as tetracyclines and metronidazole has also been attributed to their antioxidant properties. Recently, a macrolide antibiotic, azithromycin, has been found to be an effective alternative in the treatment of rosacea.